Vanda Pharmaceuticals Inc (VNDA)
4.755
-0.06
(-1.35%)
USD |
NASDAQ |
Apr 30, 16:00
4.755
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals 1 Year Total Returns (Daily): -21.50% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 29, 2024 | -21.50% |
April 26, 2024 | -26.55% |
April 25, 2024 | -28.43% |
April 24, 2024 | -27.16% |
April 23, 2024 | -27.09% |
April 22, 2024 | -24.41% |
April 19, 2024 | -18.63% |
April 18, 2024 | -20.22% |
April 17, 2024 | -19.88% |
April 16, 2024 | -37.31% |
April 15, 2024 | -37.15% |
April 12, 2024 | -39.23% |
April 11, 2024 | -37.06% |
April 10, 2024 | -36.50% |
April 09, 2024 | -36.54% |
April 08, 2024 | -34.35% |
April 05, 2024 | -28.59% |
April 04, 2024 | -26.57% |
April 03, 2024 | -26.17% |
April 02, 2024 | -42.42% |
April 01, 2024 | -39.32% |
March 28, 2024 | -39.47% |
March 27, 2024 | -43.05% |
March 26, 2024 | -42.81% |
March 25, 2024 | -42.67% |
Date | Value |
---|---|
March 22, 2024 | -40.70% |
March 21, 2024 | -41.73% |
March 20, 2024 | -42.42% |
March 19, 2024 | -42.33% |
March 18, 2024 | -42.48% |
March 15, 2024 | -40.38% |
March 14, 2024 | -39.87% |
March 13, 2024 | -38.16% |
March 12, 2024 | -37.42% |
March 11, 2024 | -35.40% |
March 08, 2024 | -37.58% |
March 07, 2024 | -39.17% |
March 06, 2024 | -38.23% |
March 05, 2024 | -35.01% |
March 04, 2024 | -32.97% |
March 01, 2024 | -28.53% |
February 29, 2024 | -30.59% |
February 28, 2024 | -30.59% |
February 27, 2024 | -29.71% |
February 26, 2024 | -29.52% |
February 23, 2024 | -33.38% |
February 22, 2024 | -35.76% |
February 21, 2024 | -35.42% |
February 20, 2024 | -38.39% |
February 16, 2024 | -37.87% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.48%
Minimum
Nov 10 2023
127.2%
Maximum
Mar 18 2021
-18.28%
Average
-32.68%
Median
1 Year Total Returns (Daily) Benchmarks
ADMA Biologics Inc | 96.42% |
INVO Bioscience Inc | -85.28% |
Johnson & Johnson | -7.56% |
Nektar Therapeutics | 94.07% |
Invivyd Inc | 89.09% |